Anti-mitotic
Showing 1 - 25 of >10,000
Gastrointestinal Stromal Tumors Trial in Changsha (Apatinib Mesylate, Sunitinib, Imatinib dosage, Dasatinib, Reveratinib)
Recruiting
- Gastrointestinal Stromal Tumors
- Apatinib Mesylate
- Sunitinib, Imatinib dosage, Dasatinib, Reveratinib
-
Changsha, Hunan, ChinaXiangya Hospital, Central South University
Mar 1, 2023
Lymphoma, Large B-Cell, Diffuse Trial in Austria, Germany (Glofitamab, Rituximab, Obinutuzumab)
Not yet recruiting
- Lymphoma, Large B-Cell, Diffuse
- Glofitamab
- +3 more
-
Linz, Austria
- +17 more
Mar 22, 2023
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Trial in Pittsburgh (Pembrolizumab, Carboplatin,
Not yet recruiting
- Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
- Pembrolizumab
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Sep 18, 2023
Study of Mast Cell Precursors
Completed
- Mastocytosis
- Healthy Volunteer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 4, 2022
Breast Cancer Trial in Istanbul (Soluble immune checkpoints)
Recruiting
- Breast Cancer
- Soluble immune checkpoints
-
Istanbul, Turkey
- +1 more
Jul 14, 2022
Gastrointestinal Stromal Tumors Trial (Imatinib Mesylate)
Recruiting
- Gastrointestinal Stromal Tumors
- Imatinib Mesylate
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Dec 22, 2022
Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the NCI (obinutuzumab, prednisone, Revlimid)
Recruiting
- Lymphoma
- +3 more
- obinutuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Brain Metastases, Small Cell Lung Cancer Trial in Birmingham (NovoTTF-200A, Stereotactic Radiosurgery (SRS))
Terminated
- Brain Metastases
- Small Cell Lung Cancer
- NovoTTF-200A
- Stereotactic Radiosurgery (SRS)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham (UAB), Hazelrig-Salter Radia
Feb 17, 2022
Standard Anti-microtubule Drugs as Assessed by Early Tumor
Recruiting
- Breast Cancer
- Breast Neoplasms
- Taxane
- +4 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Dec 10, 2021
Diabetic Neuropathies Trial in Bani Suwayf (Carnosine)
Completed
- Diabetic Neuropathies
- Carnosine
-
Banī Suwayf, Bani Suwayf, EgyptBeni Suef University faculty of pharmacy
Jun 24, 2022
SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)
Recruiting
- SCLC
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Mesothelioma Trial in Cardiff (Vinorelbine, Active Symptom Control)
Completed
- Mesothelioma
- Vinorelbine
- Active Symptom Control
-
Cardiff, United KingdomWales Cancer Trials Unit
Oct 4, 2021
NSCLC Trial in United States (NovoTTF-200T)
Recruiting
- Non-small Cell Lung Cancer
- NovoTTF-200T
-
Birmingham, Alabama
- +21 more
Aug 15, 2022
Glioblastoma, Adult Trial in Hackensack (device, drug, radiation)
Active, not recruiting
- Glioblastoma, Adult
- NovoTTF-200A
- +2 more
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Oct 7, 2021
Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Metastatic Breast Cancer
- AZD2014
- +18 more
-
Angers, France
- +24 more
Mar 8, 2022
NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)
Active, not recruiting
- Non-Small Cell Lung Cancer
- +2 more
- AZD4547
- +10 more
-
Aberdeen, United Kingdom
- +24 more
Nov 2, 2021
Stage II Melanoma Trial in Wollstonecraft (Relatlimab and nivolumab fixed dose combination (FDC))
Not yet recruiting
- Stage II Melanoma
- Relatlimab and nivolumab fixed dose combination (FDC)
-
Wollstonecraft, New South Wales, AustraliaMelanoma Institute Australia
Oct 26, 2022
Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 Trial in Houston (ABBV-399)
Completed
- Recurrent Squamous Cell Lung Carcinoma
- Stage IV Squamous Cell Lung Carcinoma AJCC V7
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2021
Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)
Not yet recruiting
- Neoplasms
- +7 more
- Biological G207
-
Birmingham, AlabamaChildren's of Alabama
Jun 1, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Suspended
- Anatomic Stage III Breast Cancer AJCC v8
- +12 more
- Copanlisib Hydrochloride
- Eribulin Mesylate
-
Gainesville, Florida
- +10 more
Nov 16, 2022
Nonsmall Cell Lung Cancer, NSCLC Trial in Worldwide (NovoTTF-200T, Immune checkpoint inhibitors or docetaxel)
Active, not recruiting
- Nonsmall Cell Lung Cancer
- NSCLC
- NovoTTF-200T
- Immune checkpoint inhibitors or docetaxel
-
Birmingham, Alabama
- +123 more
Oct 13, 2022